Microdosing Ozempic for weight loss gains popularity despite health warnings

A new trend called microdosing is emerging, where people use smaller doses of the diabetes drug Ozempic for weight loss. This practice is not FDA-approved and is not typically recommended by healthcare professionals. Microdosing may help reduce costs and side effects, but experts warn it could lead to ineffective treatment and uncontrolled diabetes. Compounded versions of the drug, often used for microdosing, carry additional risks due to lack of regulation. Healthcare providers stress the importance of consulting a clinician before changing medication regimens. They emphasize that weight loss should also involve diet and exercise changes for lasting results.